[
    [
        {
            "time": "2023-11-29",
            "original_text": "宁德时代大考已至！天量解禁17倍浮盈诱惑强烈，机构目标价607.5元和251元分歧巨大 解禁",
            "features": {
                "keywords": [
                    "宁德时代",
                    "解禁",
                    "浮盈",
                    "机构目标价"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "新能源"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "宁德时代大考已至！天量解禁17倍浮盈诱惑强烈，机构目标价607.5元和251元分歧巨大 解禁",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-11-29",
            "original_text": "蓝帆医疗：目前手套业务订单稳步推进",
            "features": {
                "keywords": [
                    "蓝帆医疗",
                    "手套业务",
                    "订单"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "蓝帆医疗：目前手套业务订单稳步推进",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-11-29",
            "original_text": "医药生物行业跨市场周报：2021年医保目录调整方案征求意见 多个国产创新药有望进入谈判",
            "features": {
                "keywords": [
                    "医药生物",
                    "医保目录",
                    "国产创新药",
                    "谈判"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业跨市场周报：2021年医保目录调整方案征求意见 多个国产创新药有望进入谈判",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]